Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

New research indicates that cannabinoids could be efficacious pain management options

by Eric W. Dolan
July 6, 2019
in Psychopharmacology
(Photo credit: Iarygin Andrii)

(Photo credit: Iarygin Andrii)

Share on TwitterShare on Facebook
Follow PsyPost on Google News

Cannabis and similar substances that interact with the body’s natural cannabinoid receptors could be viable candidates for pain management and treatment, according to new research published in the journal Experimental and Clinical Psychopharmacology.

“Currently, more than 30 states have policies in place that permit medicinal cannabis use; many of these cite pain conditions as inclusionary criteria. However, despite expanding use, what we know about ‘how’ and ‘why’ cannabinoids alleviate pain remains poorly understood,” said study author Julio A. Yanes, a graduate research assistant and National Research Service Award Fellow at Auburn University.

The researchers conducted a meta-analysis of previous research that had examined cannabinoid-induced alterations in pain ratings. They identified 25 peer-reviewed studies that met their criteria, which included 2,248 participants in total.

All of the studies compared either whole-plant cannabis, cannabis extracts, or synthetic cannabinoids to a placebo.

The meta-analysis found that cannabinoid administration was associated with greater pain reduction than placebo administration.

“Although our meta-analysis results suggest that cannabinoids are efficacious pain management options, more research is needed,” Yanes told PsyPost.

“For example, our follow-up meta-regression results revealed that study sample size was associated with observed pain reduction, such that smaller samples were associated with bigger effects. Thus, large (i.e., sufficiently powered) studies are warranted.”

Scientists are learning more about how cannabis interacts with the brain and the body’s endogenous cannabinoid system. But the mechanisms behind cannabis-induced pain reduction are still unclear.

“Our meta-analysis doesn’t address ‘how’ or ‘why’ cannabinoids were more effective than placebos. One important challenge facing the field is to determine the neurobiological mechanisms that may support cannabis-related pain reduction,” Yanes said.

The study, “Effects of Cannabinoid Administration for Pain: A Meta-Analysis and Meta-Regression“, was authored by Julio A. Yanes, Zach E. McKinnell, Meredith A. Reid, Jessica N. Busler, Jesse S. Michel, Melissa M. Pangelinan, Matthew T. Sutherland, Jared W. Younger, Raul Gonzalez, and Jennifer L. Robinson.

TweetSendScanShareSendPin2ShareShareShareShareShare

RELATED

Psychedelic compound blurs boundary between self and others in the brain, study finds
Ayahuasca

Psychedelic compound blurs boundary between self and others in the brain, study finds

July 2, 2025

A recent study found that a DMT/harmine formulation blurs the brain’s distinction between self and other faces, disrupting self-referential processing while preserving recognition of familiar faces, suggesting a neural basis for psychedelic-induced ego dissolution.

Read moreDetails
Researchers identify neural mechanism behind memory prioritization
MDMA

New study reveals how MDMA rewires serotonin and oxytocin systems in the brain

June 30, 2025

Researchers found that MDMA reduces anxiety and enhances social behavior in zebrafish by altering key neurochemical systems. The drug suppressed serotonin signaling, boosted oxytocin receptor expression, and modulated brain signaling proteins involved in emotional regulation.

Read moreDetails
Stimulant medication improves working memory of children with ADHD, study finds
ADHD

New study exposes gap between ADHD drug use and safety research in children

June 30, 2025

A nationwide Finnish study shows that children with ADHD stay on medication for over three years on average. Yet, controlled safety data for these medications in children exists for only one year, highlighting a gap in long-term evidence.

Read moreDetails
Regular psychedelic users exhibit different brain responses to self-related thoughts, study finds
Neuroimaging

Regular psychedelic users exhibit different brain responses to self-related thoughts, study finds

June 28, 2025

A new study suggests that regular users of psychedelics may process self-related thoughts differently at both psychological and brain levels, revealing altered patterns of brain activity during self-reflection compared to non-users who intend to try psychedelics.

Read moreDetails
Can Acacia catechu and Scutellaria baicalensis extracts enhance brain function?
Dementia

Ashwagandha extract boosts memory and cognition in people with mild cognitive impairment, study finds

June 27, 2025

Researchers found that a standardized extract of ashwagandha improved memory, attention, and spatial reasoning in adults with mild cognitive impairment, outperforming a placebo in a two-month clinical trial with no reported side effects.

Read moreDetails
Psychedelic use linked to increased risk of unusual visual experiences
Ayahuasca

Study links moderate awe in psychedelic ayahuasca journeys to better well-being

June 21, 2025

A new study published in the Journal of Psychoactive Drugs suggests that while awe can be transformative during ayahuasca retreats, there’s a limit. Experiences marked by excessive vastness were linked to lower well-being, challenging assumptions about awe’s universal benefits.

Read moreDetails
Cannabis intoxication alters metabolism, but frequent users show fewer effects
Cannabis

Regular cannabis use linked to changes in brain activity regulating movement

June 20, 2025

Researchers have discovered that frequent cannabis users show reduced spontaneous brain activity in the motor cortex, and this neural suppression is tied to cannabis use severity and response speed, even though overall task performance remained comparable to non-users.

Read moreDetails
About 8% of psychedelic users report inappropriate sexual contact by guides
Psychedelic Drugs

Study links psychedelic use in illegal settings to increased psychotic and manic symptoms

June 18, 2025

New research suggests that naturalistic psychedelic use may worsen psychotic and manic symptoms when used in illegal settings. People with schizophrenia or bipolar I disorder appeared especially vulnerable to these effects, highlighting the importance of context and psychiatric background.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Peppermint tea boosts memory and attention—but why?

Psychedelic compound blurs boundary between self and others in the brain, study finds

Could creatine slow cognitive decline? Mouse study reveals promising effects on brain aging

ChatGPT and “cognitive debt”: New study suggests AI might be hurting your brain’s ability to think

Frequent dreams and nightmares surged worldwide during the COVID-19 pandemic

Vagus nerve signals influence food intake more in higher socio-economic groups

People who think “everyone agrees with me” are more likely to support populism

What is the most attractive body fat percentage for men? New research offers an answer

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy